David A. Alagpulinsa, PhD
Biography
Research & Publications
Appointments
Biography
Dr. Alagpulinsa earned a bachelor’s degree in pharmacy (BPharm) from the Kwame Nkrumah University of Science & Technology in Kumasi, Ghana, and a doctorate (PhD) in Interdisciplinary Biomedical Sciences from the University of Arkansas for Medical Sciences at Little Rock, USA. He completed a postdoctoral training in the Department of Medicine at the Massachusetts General Hospital & Harvard Medical School, and became a faculty instructor in Medicine and Investigation thereafter before joining the faculty in the Yale Center for Molecular and Systems Metabolism and Department of Comparative Medicine at Yale University School of Medicine in 2023. The primary interest of Dr. Alagpulinsa's research is in metabolic diseases, with particular emphasis on type 1 diabetes and atherosclerotic cardiovascular disease.
Education & Training
- InstructorMassachusetts General Hospital & Harvard Medical School (2023)
- PostdocMassachusetts General Hospital & Harvard Medical School (2021)
- PhDUniversity of Arkansas for Medical Sciences (2015)
Honors & Recognition
Award | Awarding Organization | Date |
---|---|---|
Ad hoc Reviewer | NIH HAI Study Section | 2023 |
Keystone Fellow | Keystone Symposia | 2023 |
JDRF Diversifying Diabetes Research Talent in Academia Award | Juvenile Diabetes Research Foundation | 2022 |
Poster of Distinction Award | Massachusetts General Hosptial | 2021 |
Physician/Scientist Development Award | Massachusetts General Hospital | 2020 |
Tosteson & Fund for Medical Discovery Postdoctoral Fellowship | Massachusetts General Hospital | 2019 |
American Diabetes Association Pathway to Stop Diabetes Initiator Award, Nominee | Massachusetts General Hospital | 2019 |
Poster of Distinction Award | Massachusetts General Hospital | 2018 |
Abstract Achievement Award | American Society of Hematology | 2014 |
Bill & Melinda Gates Global Health Travel Award | Keystone Symposia | 2008 |
Professional Service
Organization | Role | Date |
---|---|---|
National Institutes of Health HAI Study Section | Ad-hoc reviewer | 2023 - Present |
Haematologica; American Journal of Transplantation; Trends in Molecular Medicine; Pharmacology & Therapeutics; Frontiers in Cell and Developmental Biology; The FASEB Journal; etc. | Reviewer | 2019 - Present |